NeoStrata Ultra Smoothing Cream AHA 10

NeoStrata Ultra Smoothing Cream AHA 10

NeoStrata Ultra Smoothing Cream AHA 10

Resurface skin with this anti aging face cream ideally suited for first time AHA users to target photoaging skin. 86% noted improved skin smoothness and rejuvenation after four weeks of twice daily use.
  • Ultra-rich, anti-aging facial cream that targets signs of aging
  • Formulated with 8% Glycolic acid and 2% Citric acid
  • Ideal for first time Alpha Hydroxy Acid (AHA) users with non-sensitive skin

Ideal for new users of Glycolic Acid, this antioxidant exfoliating cream moisturizes and restores a visibly smoother appearance to skin. Clinically proven to significantly improve firmness, mottled pigmentation and overall clarity when used with NeoStrata Ultra Daytime Smoothing Cream. Oil-free. Fragrance-Free. Dye-Free. Paba-Free. Non-comedogenic. Formulated with 8% Glycolic Acid and 2% Citric Acid.

Recommended Usage: Twice daily/AM under sunscreen, and PM as tolerated

Key Ingredients: Glycolic Acid, Citric Acid, Arginine-Amphoteric

pH 3.8

Size: 1.4 oz. tube

HERITAGE
The creators of NeoStrata Company, Inc., Drs. Eugene Van Scott and Ruey Yu are internationally recognized for making the ground breaking discovery that Alpha Hydroxy Acids (AHAs) have profound beneficial effects on human skin. They discovered that AHA compounds such as Glycolic Acid and Lactic Acid are beneficial both in the treatment of dermatological conditions, encouraging cell turnover, and in stimulating prematurely aged or damaged skin to rejuvenate itself, thereby revolutionizing the treatment of aging skin.

The Partnership
Doctors Van Scott and Yu began working together in 1968 at Temple University in Philadelphia, sharing a mutual interest in diseases of the skin. Since more than half of all skin problems are due to difficulties in shedding and forming the stratum corneum, the doctors were determined to find ways to positively influence the formation of new layers of the skin. This partnership has spanned five decades and still continues today.

The Study
During a study to evaluate the effects of natural, physiologic type substances on patients with ichthyosis, a rare disorder with severe scaly skin, Drs. Van Scott and Yu discovered that this class of compounds has a profound effect on the development, maturation, and turnover of both normal and diseased epidermal skin. They were elated when ichthyosis patients returned with normal appearing skin where these compounds were applied. They named the compounds alpha-hydroxyacids (AHAs) and filed for their first patent (US Patent No. 3,879,537), entitled Treatment of Ichthyosiform Dermatoses, dated April 22, 1975.

Resulting from this early work was the first AHA prescription topical lotion, called Lac-Hydrin®, which was licensed to and marketed by Westwood (a division of Bristol-Myers Squibb). Lac-Hydrin® was the best-selling prescription treatment for dry skin for more than 10 years. AHAs such as Glycolic Acid and Lactic Acid continue to be broadly used in numerous products that treat dry skin.

Antiaging Breakthrough
While the initial discoveries relating to the use of AHAs were therapeutic in nature, a monumental breakthrough in the mid-1980s caused a revolution in antiaging skincare. The continuing research and clinical experience of Drs. Van Scott and Yu revealed that AHAs are not only beneficial in the treatment of dermatological conditions, but are also effective in stimulating older damaged skin to rejuvenate itself. Avon’s Anew® in the early 1990s was the first cosmetic skincare product to license the antiaging benefits of AHAs, and numerous cosmetic and pharmaceutical companies followed suit.

No Comments

Post a Comment